Physician
Gastroenterology
Dr. Jacqueline G. O'Leary, MD
|
|
Give Review
Jacqueline O'Leary works in the field of Gastroenterology. She studied medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. She received 2 awards: "Regional Top Doctor" and "Meaningful Use Stage 1 Certification". Jacqueline G. O'Leary, MD is a published MD as well. She has 31 publications published. The latest was: Protecting the kidney in liver transplant candidates Practice-Based Recommendations from the American Society of Transplantation Liver and Intestine Community of Pract... She accepts Medicare payments and is listed with Medicare.gov.
Publications
- Management of the Critically Ill Patient with Cirrhosis: A Multidisciplinary Perspective.
- The changing liver transplant waitlist: an emerging liver purgatory?
- Post-Liver Transplant Hepatitis C Therapy.
- Telaprevir- and Boceprevir-Based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.
- Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
- Hepatitis C Genotype Influences Post-Liver Transplant Outcomes.
- Acute-On-Chronic Liver Failure.
- A US Multicenter Study of Hepatitis C Treatment of Liver Transplant Recipients with Protease-Inhibitor Triple Therapy.
- Donor-specific alloantibodies are associated with fibrosis progression after liver-transplantation in HCV-infected patients.
- Impact of donor-specific antibodies on results of liver transplantation.
- De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients.
- Use of protease inhibitors in liver transplant recipients.
- Effect of tacrolimus on survival in Hepatitis C-infected patients after liver transplantation.
- Is MELD Fit Enough?
- Patients with NASH and Cryptogenic Cirrhosis Are Less Likely Than Those with Hepatitis C to Receive Liver Transplants.
- Inferior vena cava stent resolves hepatopulmonary Syndrome in an adult with a spontaneous inferior vena cava-portal vein shunt.
- Conivaptan increases serum sodium in hyponatremic patients with end-stage liver Disease.
- Post-liver transplant survival in Hepatitis C patients is improving over time.
- Indications for liver transplantation.
- De novo autoimmune Hepatitis during immune reconstitution in an HIV-infected patient receiving highly active antiretroviral therapy.
- Cholestasis and cholestatic Syndromes.
- Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: a pilot clinical trial.
- Predicting surgical risk in patients with Cirrhosis: from art to science.
- Management of Hepatitis C virus coinfection in HIV-infected persons.
- T cell- and B cell-independent adaptive immunity mediated by natural killer cells.
- Limiting Hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression.
- High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant.
- Hepatitis C virus replication and potential targets for direct-acting agents.
- Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men.
- Protecting the kidney in liver transplant candidates Practice-Based Recommendations from the American Society of Transplantation Liver and Intestine Community of Pract...
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
Education
-
Massachusetts General Hospital -
University of Texas Southwestern Medical School -
University of California San Francisco School of Medicine
Hospital
-
Baylor University Medical Center
Drug Facts
| NPI NUMBER | 1336121565 | |
| NPPES Provider LastName | O'LEARY | |
| NPPES Provider FirstName | JACQUELINE | |
| NPPES Provider ZIPCode | 752462003 | |
| NPPES Provider State | TX | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 936.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1336121565 |
| Last Name Of The Provider | O'LEARY |
| First Name Of The Provider | JACQUELINE |
| View All |
Similar Doctors
|
Dr. Gerald M. Isbell III, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert P. Perrillo, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sally B. Brooks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lyman E. Bilhartz, MD |
|
|
Dr. Paul R. Tarnasky, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|